196 related articles for article (PubMed ID: 10703664)
1. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis.
Regele HM; Fillipovic E; Langer B; Poczewki H; Kraxberger I; Bittner RE; Kerjaschki D
J Am Soc Nephrol; 2000 Mar; 11(3):403-412. PubMed ID: 10703664
[TBL] [Abstract][Full Text] [Related]
2. Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies.
Raats CJ; van den Born J; Bakker MA; Oppers-Walgreen B; Pisa BJ; Dijkman HB; Assmann KJ; Berden JH
Am J Pathol; 2000 May; 156(5):1749-65. PubMed ID: 10793086
[TBL] [Abstract][Full Text] [Related]
3. Expression of sialidase and dystroglycan in human glomerular diseases.
Vogtländer NP; van der Vlag J; Bakker MA; Dijkman HB; Wevers RA; Campbell KP; Wetzels JF; Berden JH
Nephrol Dial Transplant; 2010 Feb; 25(2):478-84. PubMed ID: 19755471
[TBL] [Abstract][Full Text] [Related]
4. Podocyte flattening and disorder of glomerular basement membrane are associated with splitting of dystroglycan-matrix interaction.
Kojima K; Davidovits A; Poczewski H; Langer B; Uchida S; Nagy-Bojarski K; Hovorka A; Sedivy R; Kerjaschki D
J Am Soc Nephrol; 2004 Aug; 15(8):2079-89. PubMed ID: 15284294
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ
Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
[TBL] [Abstract][Full Text] [Related]
6. Podocyte phenotypes as defined by expression and distribution of GLEPP1 in the developing glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS. A dedifferentiation hypothesis for the nephrotic syndrome.
Sharif K; Goyal M; Kershaw D; Kunkel R; Wiggins R
Exp Nephrol; 1998; 6(3):234-44. PubMed ID: 9639039
[TBL] [Abstract][Full Text] [Related]
7. Glomerular anionic sites in minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Kitano Y; Yoshikawa N; Nakamura H
Clin Nephrol; 1993 Oct; 40(4):199-204. PubMed ID: 8261675
[TBL] [Abstract][Full Text] [Related]
8. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
[TBL] [Abstract][Full Text] [Related]
9. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
10. Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus.
Kanasaki K; Kanda Y; Palmsten K; Tanjore H; Lee SB; Lebleu VS; Gattone VH; Kalluri R
Dev Biol; 2008 Jan; 313(2):584-93. PubMed ID: 18082680
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
[TBL] [Abstract][Full Text] [Related]
12. Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease.
Smeets B; Stucker F; Wetzels J; Brocheriou I; Ronco P; Gröne HJ; D'Agati V; Fogo AB; van Kuppevelt TH; Fischer HP; Boor P; Floege J; Ostendorf T; Moeller MJ
Am J Pathol; 2014 Dec; 184(12):3239-48. PubMed ID: 25307344
[TBL] [Abstract][Full Text] [Related]
13. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
[TBL] [Abstract][Full Text] [Related]
14. Ezrin--a useful factor in the prognosis of nephrotic syndrome in children: an immunohistochemical approach.
Ostalska-Nowicka D; Zachwieja J; Nowicki M; Kaczmarek E; Siwinska A; Witt M
J Clin Pathol; 2006 Sep; 59(9):916-20. PubMed ID: 16522749
[TBL] [Abstract][Full Text] [Related]
15. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
Agrawal V; Prasad N; Jain M; Pandey R
Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
[TBL] [Abstract][Full Text] [Related]
16. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
18. Podocytes loose their adhesive phenotype in focal segmental glomerulosclerosis.
Kemeny E; Mihatsch MJ; Dürmüller U; Gudat F
Clin Nephrol; 1995 Feb; 43(2):71-83. PubMed ID: 7736682
[TBL] [Abstract][Full Text] [Related]
19. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
[TBL] [Abstract][Full Text] [Related]
20. Synaptopodin immunoexpression in steroid-responsive and steroid-resistant minimal change disease and focal segmental glomerulosclerosis.
Wagrowska-Danilewicz M; Danilewicz M
Nefrologia; 2007; 27(6):710-5. PubMed ID: 18336100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
